OrbiMed Advisors LLC's Form 4 filing
SpringWorks Therapeutics, Inc. (SWTX) · filed Sep 14, 2022
- Accession no.
- 0000947871-22-000964
- Filed
- Sep 14, 2022, 4:24 PM ET
- Trade date
- Sep 12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $4.92M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2022 | Common Stock | SSaleDisposed | −123,897 | $31.96 | −$3,959,748.12 | 5,629,842 | Indirect | |
| Sep 12, 2022 | Common Stock | SSaleDisposed | −30,000 | $31.98 | −$959,400 | 5,599,842 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.